IRON News and Press, Disc Medicine Inc. From 02/25/26

2026-02-25 15:11:16 ET On February 17, 2026, Great Point Partners disclosed a new position in Disc Medicine (NASDAQ:IRON) , acquiring 250,000 shares worth an estimated $19.85 million. According to an SEC filing dated February 17, 2026, Great Point Partners reported a new pos...

2026-02-19 12:26:54 ET The last time I spoke about Disc Medicine, Inc. ( IRON ), it was with respect to a Seeking Alpha article entitled " Disc Medicine: NDA Submission And CNPV For Bitopertin Further Boost Shareholder Value ". With that article, I had rated the stock a ...

2026-02-17 16:34:59 ET Disc Medicine, Inc. (IRON) Discusses FDA Complete Response Letter and Path Forward for Bitopertin Regulatory Approval February 17, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Disc Medicine, Inc. (IRON) Discusses ...

2026-02-17 10:40:09 ET Thesis As you know by now from the 21% stock slide, the FDA has issued a CRL to Disc Medicine Inc. ( IRON ) for bitopertin. However, on the surface, it appears to be more of a regulatory disagreement and not about whether the drug actually lowers its bioch...

2026-02-17 08:15:08 ET BMO Capital analyst issues OUTPERFORM recommendation for IRON on February 17, 2026 12:56PM ET. The previous analyst recommendation was Outperform. IRON was trading at $55.95 at issue of the analyst recommendation. The overall analyst consensus : BU...

2026-02-13 16:59:41 ET More on Disc Medicine Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Disc Medicine: RALLY-MF Data ...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 2.5% to $1.765 on volume of 586,454,072 shares Iveda Solutions Inc. (IVDA) rose 18.2% to $0.3429 on volume of 194,121,230 shares ProShares UltraShort Silver -2x Shares (ZSL) fell 6...

FDA acknowledged that AURORA and BEACON provided sufficient evidence that bitopertin significantly lowers PPIX and that there is a strong mechanistic and biological plausibility supporting the use of the PPIX biomarker in protoporphyria FDA indicated a need to see the results of the ongoing Phas...

2026-01-15 10:15:04 ET Wedbush analyst issues OUTPERFORM recommendation for IRON on January 15, 2026 03:20PM ET. The previous analyst recommendation was Outperform. IRON was trading at $72.51 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2026-01-15 07:10:00 ET More on Disc Medicine, Sanofi, etc. Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Disc Medicine, Inc. (IRON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Sanofi (SAN:CA)...